The following seems to be directed to doctors, but if appropriate you may want to suggest it to your Hem/Onc or GP. The CLL experts listed are all USA, but most of the choices are available world wide, and extensive predictive testing is not required.
Personalized Treatment Options From 5 Experts for People With CLL
-
Farrukh T. Awan, MD | Jennifer R. Brown, MD, PhD | Nicole Lamanna, MD |
Anthony Mato, MD, MSCE | Jeff P. Sharman, MD
-
Access this updated, free Interactive Decision Support Tool to get expert, individualized treatment recommendations for your patients with CLL based on specific patient characteristics that YOU enter.
Access the Tool - clinicaloptions.com/oncolog...
-
Don't have the CCO Interactive Decision Support Tool app?
Get access to all CCO decision support tools by clicking the app store button below or search “Decision Support” in either the App Store or Google Play store.
-
Provided by Clinical Care Options, LLC.
Produced in collaboration with the CLL Society.
-
Len
Que dicen,?
Translated: What do they say,?-
It's an interactive tool, you need to answer a series of questions about the CLL patient and treatment history to get a suggestion for the next treatment.
-
Len
Do you know if in any case they talk about reducing ibrutinib? Days or Doses. Thx.
I don't know what the interactive tool says, but I can only tell you what I was told by NIH a couple years ago: "There aren't any routine reductions in reducing Ibrutinib from 420 mg." If there are intolerable side effects, however, the dosage can be reduced or stopped.
THAT IS A REDUCTION ROUTINE IN ITSELF.
I only told you what NIH told me. If you think you know better, suit yourself.
And I told you that it was a reduction routine by itself. Yes.